Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $397.40 | 12 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $120.65 | 1 | $0 (2019) |
| HEARTFLOW, INC. | $83.33 | 1 | $0 (2024) |
| Abbott Laboratories | $67.93 | 3 | $0 (2022) |
| iRhythm Technologies, Inc. | $54.23 | 2 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $36.62 | 3 | $0 (2020) |
| PFIZER INC. | $21.73 | 1 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $12.91 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $83.33 | 1 | HEARTFLOW, INC. ($83.33) |
| 2022 | $89.66 | 4 | Abbott Laboratories ($67.93) |
| 2020 | $78.04 | 4 | iRhythm Technologies, Inc. ($54.23) |
| 2019 | $133.46 | 2 | Boston Scientific Corporation ($120.65) |
| 2018 | $12.91 | 1 | Novartis Pharmaceuticals Corporation ($12.91) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/26/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $83.33 | General |
| Category: Coronary | ||||||
| 12/07/2022 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/16/2022 | Abbott Laboratories | PERCLOSE PROGLIDE (Device) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Vascular | ||||||
| 03/21/2022 | Abbott Laboratories | SUPERA (Device) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Vascular | ||||||
| 01/11/2022 | Abbott Laboratories | PERCLOSE PROGLIDE (Device) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: Vascular | ||||||
| 07/13/2020 | iRhythm Technologies, Inc. | ZIO Patch (Device) | Food and Beverage | In-kind items and services | $36.39 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/02/2020 | iRhythm Technologies, Inc. | ZIO Patch (Device) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/28/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.00 | General |
| Category: Cardiovascular | ||||||
| 01/13/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.81 | General |
| Category: Cardiovascular | ||||||
| 09/09/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.81 | General |
| Category: Cardiovascular | ||||||
| 05/06/2019 | Boston Scientific Corporation | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $120.65 | General |
| Category: STRUCTURAL HEART | ||||||
| 09/26/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 959 | 1,692 | $290,225 | $111,736 |
| 2022 | 17 | 1,198 | 2,016 | $337,975 | $121,788 |
| 2021 | 19 | 1,246 | 2,289 | $382,625 | $145,753 |
| 2020 | 22 | 1,318 | 2,290 | $396,670 | $146,031 |
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 3 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2021 | 12 | 22 | $2,420 | $1,237 | 51.1% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 165 | 186 | $3,720 | $1,222 | 32.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 13 | 13 | $1,755 | $1,143 | 65.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 21 | 29 | $1,595 | $871.74 | 54.7% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 62 | 68 | $2,720 | $683.38 | 25.1% |
| 93227 | Heart rhythm tracing, analysis, and interpretation of 48-hour ekg | Facility | 2021 | 26 | 31 | $1,705 | $459.11 | 26.9% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Facility | 2021 | 25 | 25 | $2,000 | $431.25 | 21.6% |
| 93018 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report | Facility | 2021 | 25 | 25 | $1,625 | $287.50 | 17.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 106 | 674 | $80,880 | $39,214 | 48.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 219 | 427 | $36,295 | $19,007 | 52.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 94 | 96 | $25,920 | $15,200 | 58.6% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2020 | 155 | 168 | $67,200 | $9,865 | 14.7% |
| 78452 | Nuclear medicine study of vessels of heart using drugs or exercise multiple studies | Office | 2020 | 27 | 27 | $22,950 | $9,454 | 41.2% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2020 | 62 | 62 | $24,800 | $8,715 | 35.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 35 | 78 | $10,140 | $6,517 | 64.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 38 | 56 | $9,520 | $6,244 | 65.6% |
| 93458 | Insertion of catheter in left heart for imaging of blood vessels or grafts and left lower heart | Facility | 2020 | 26 | 26 | $23,400 | $5,261 | 22.5% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2020 | 27 | 27 | $9,275 | $5,139 | 55.4% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2020 | 19 | 74 | $7,400 | $3,347 | 45.2% |
| 78452 | Nuclear medicine study of vessels of heart using drugs or exercise multiple studies | Facility | 2020 | 49 | 49 | $41,650 | $3,062 | 7.4% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 18 | 19 | $3,800 | $2,844 | 74.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 39 | 49 | $4,900 | $2,812 | 57.4% |
| 93015 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report | Office | 2020 | 30 | 34 | $7,650 | $1,577 | 20.6% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 148 | 175 | $3,460 | $1,191 | 34.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 14 | 16 | $2,080 | $1,134 | 54.5% |
About Dr. Ragoor Reddy, M.D
Dr. Ragoor Reddy, M.D is a Cardiovascular Disease healthcare provider based in Greensburg, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1336140326.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ragoor Reddy, M.D has received a total of $397.40 in payments from pharmaceutical and medical device companies, with $83.33 received in 2024. These payments were reported across 12 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($397.40).
As a Medicare-enrolled provider, Reddy has provided services to 4,721 Medicare beneficiaries, totaling 8,287 services with total Medicare billing of $525,307. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Greensburg, PA
- Active Since 08/02/2005
- Last Updated 01/06/2014
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1336140326
Products in Payments
- WATCHMAN (Device) $120.65
- FFRct (Device) $83.33
- ZIO Patch (Device) $54.23
- PERCLOSE PROGLIDE (Device) $43.65
- ELIQUIS (Drug) $36.62
- SUPERA (Device) $24.28
- VYNDAQEL (Drug) $21.73
- ENTRESTO (Drug) $12.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Greensburg
Sandeep Arora, M.d, M.D
Cardiovascular Disease — Payments: $15,288
Fouad Jabbour, M.d, M.D
Cardiovascular Disease — Payments: $7,916
Rishi Kad, M.d, M.D
Cardiovascular Disease — Payments: $7,820
Dr. Stephen Bowser, M.d, M.D
Cardiovascular Disease — Payments: $5,222
Lawrence Denino, M.d, M.D
Cardiovascular Disease — Payments: $1,879
James Adisey, M.d, M.D
Cardiovascular Disease — Payments: $1,490